Ambac's turnaround story hinges on the imminent sale of its legacy business to Oaktree, with a key regulatory hearing set for September 3. Despite a 24% stock decline, AMBC has executed on its transition to specialty P&C insurance, growing its distribution segment nearly 5x year-over-year. The legacy sale would radically improve the company's balance sheet, eliminate debt, and boost book value ...
Ambac Financial Group, Inc. (NYSE:AMBC ) Q2 2025 Earnings Conference Call August 8, 2025 8:30 AM ET Company Participants Charles Joseph Sebaski - MD & Head of Investor Relation Claude L. LeBlanc - President, CEO & Director David Trick - Executive VP, CFO & Treasurer Conference Call Participants Deepak Sarpangal - Unidentified Company Repertoire Partners LP - Unidentified Company Mark Douglas Hu...
NEW YORK--(BUSINESS WIRE)--Ambac reports that the Wisconsin Office of the Commissioner of Insurance has scheduled a hearing on the sale of Ambac's legacy business.
NEW YORK--(BUSINESS WIRE)--Ambac Financial Group and Oaktree announce an extension to the stock purchase agreement for the Financial Guarantee business.
Ambac is significantly undervalued at 0.39x FWD book value, with upside potential if the $420M Oaktree Capital deal closes. Ongoing share repurchases and a reduced share count signal management's confidence and could support higher stock prices. Strategic investments in specialty insurance and potential M&A activity may accelerate growth and attract new investors.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.